Literature DB >> 10230467

[The treatment of thyroid carcinomas: the results of a prospective multicenter study].

T Kuwert.   

Abstract

Entities:  

Mesh:

Year:  1999        PMID: 10230467     DOI: 10.1007/bf02742367

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Long-term follow-up of 92 patients with locally advanced follicular or papillary thyroid cancer after combined treatment.

Authors:  C Glanzmann; U M Lütolf
Journal:  Strahlenther Onkol       Date:  1992-05       Impact factor: 3.621

2.  Survival rates in patients with differentiated thyroid carcinoma. Influence of postoperative external radiotherapy.

Authors:  G Benker; T Olbricht; D Reinwein; C Reiners; W Sauerwein; U Krause; M L Mlynek; H Hirche
Journal:  Cancer       Date:  1990-04-01       Impact factor: 6.860

3.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group.

Authors:  D P Byar; S B Green; P Dor; E D Williams; J Colon; H A van Gilse; M Mayer; R J Sylvester; M van Glabbeke
Journal:  Eur J Cancer       Date:  1979-08       Impact factor: 9.162

4.  Survival of differentiated thyroid carcinoma studied in 500 patients.

Authors:  H Lerch; O Schober; T Kuwert; H B Saur
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

5.  Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group.

Authors:  S I Sherman; J D Brierley; M Sperling; K B Ain; S T Bigos; D S Cooper; B R Haugen; M Ho; I Klein; P W Ladenson; J Robbins; D S Ross; B Specker; T Taylor; H R Maxon
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

6.  Natural history, treatment, and course of papillary thyroid carcinoma.

Authors:  L J DeGroot; E L Kaplan; M McCormick; F H Straus
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.